Home » Analyst Articles – US
PTC (NASDAQ:PTC) Given New $195.00 Price Target at KeyCorp
PTC (NASDAQ:PTC – Free Report) had its price objective cut by KeyCorp from $210.00 to $195.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the technology company’s... More of this article »
Relay Therapeutics (NASDAQ:RLAY) Given New $17.00 Price Target at Citizens Jmp
Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective raised by Citizens Jmp from $15.00 to $17.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a market outperform... More of this article »
Veritone (NASDAQ:VERI) Given “Buy” Rating at D. Boral Capital
D. Boral Capital restated their buy rating on shares of Veritone (NASDAQ:VERI – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage currently has a $23.00 price target on the stock. A number... More of this article »
Armada Hoffler Properties (NYSE:AHRT) Price Target Lowered to $7.00 at Scotiabank
Armada Hoffler Properties (NYSE:AHRT – Free Report) had its price objective lowered by Scotiabank from $7.50 to $7.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector... More of this article »
Sharplink Gaming (NASDAQ:SBET) Given “Buy” Rating at Canaccord Genuity Group
Canaccord Genuity Group restated their buy rating on shares of Sharplink Gaming (NASDAQ:SBET – Free Report) in a report released on Tuesday morning,Benzinga reports. The firm currently has a $16.00 target price on the stock. Several... More of this article »
First Solar (NASDAQ:FSLR) Price Target Cut to $269.00 by Analysts at Guggenheim
First Solar (NASDAQ:FSLR – Free Report) had its price objective reduced by Guggenheim from $312.00 to $269.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the solar cell... More of this article »
Alto Neuroscience (NYSE:ANRO) Given Buy Rating at Chardan Capital
Chardan Capital reiterated their buy rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a $30.00 price objective on the... More of this article »
Olema Pharmaceuticals (NASDAQ:OLMA) Given New $38.00 Price Target at Guggenheim
Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price objective trimmed by Guggenheim from $40.00 to $38.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. A... More of this article »
Urgent.ly’s (ULY) Neutral Rating Reaffirmed at Chardan Capital
Chardan Capital reaffirmed their neutral rating on shares of Urgent.ly (NASDAQ:ULY – Free Report) in a report released on Tuesday,Benzinga reports. The brokerage currently has a $5.50 price target on the stock, down from their... More of this article »
Telos (NASDAQ:TLS) Price Target Lowered to $8.00 at Wedbush
Telos (NASDAQ:TLS – Free Report) had its target price reduced by Wedbush from $10.00 to $8.00 in a research note released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock. Several other... More of this article »
Open Lending’s (LPRO) “Hold” Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reiterated their hold rating on shares of Open Lending (NASDAQ:LPRO – Free Report) in a research note published on Tuesday morning,Benzinga reports. Canaccord Genuity Group currently has a $2.00 price... More of this article »
Humacyte (NASDAQ:HUMA) Receives Buy Rating from D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report issued on Tuesday,Benzinga reports. The brokerage currently has a $25.00 target price on the stock. HUMA has been the... More of this article »
NeuroSense Therapeutics (NASDAQ:NRSN) Receives “Buy” Rating from D. Boral Capital
D. Boral Capital restated their buy rating on shares of NeuroSense Therapeutics (NASDAQ:NRSN – Free Report) in a report issued on Tuesday morning,Benzinga reports. They currently have a $14.00 target price on the stock. A number... More of this article »
Logitech International (NASDAQ:LOGI) Downgraded by UBS Group to Neutral
UBS Group cut shares of Logitech International (NASDAQ:LOGI – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday, Marketbeat reports. Other equities analysts have also issued reports about... More of this article »
VinFast Auto (NASDAQ:VFS) Receives Buy Rating from Chardan Capital
Chardan Capital restated their buy rating on shares of VinFast Auto (NASDAQ:VFS – Free Report) in a research note released on Tuesday,Benzinga reports. The firm currently has a $5.50 target price on the stock. Several other... More of this article »
Serve Robotics (NASDAQ:SERV) Given New $16.00 Price Target at Cantor Fitzgerald
Serve Robotics (NASDAQ:SERV – Free Report) had its price target lowered by Cantor Fitzgerald from $17.00 to $16.00 in a report published on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock. SERV... More of this article »
Wedbush Issues Positive Forecast for Alto Neuroscience (NYSE:ANRO) Stock Price
Alto Neuroscience (NYSE:ANRO – Free Report) had its target price boosted by Wedbush from $13.00 to $22.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a neutral rating... More of this article »
PTC (NASDAQ:PTC) Now Covered by Barclays
Barclays started coverage on shares of PTC (NASDAQ:PTC – Free Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The firm issued an overweight rating and a $180.00 price target on the technology... More of this article »
Ocugen (NASDAQ:OCGN) Now Covered by Canaccord Genuity Group
Canaccord Genuity Group started coverage on shares of Ocugen (NASDAQ:OCGN – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The firm issued a buy rating and a $12.00 price target... More of this article »
MarketAxess (NASDAQ:MKTX) Downgraded to Hold Rating by Argus
Argus lowered shares of MarketAxess (NASDAQ:MKTX – Free Report) from a buy rating to a hold rating in a research note released on Tuesday, Marketbeat.com reports. Several other equities research analysts have also commented on... More of this article »
Arthur J. Gallagher & Co. (NYSE:AJG) Now Covered by Analysts at Royal Bank Of Canada
Royal Bank Of Canada began coverage on shares of Arthur J. Gallagher & Co. (NYSE:AJG – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued an outperform rating and a $260.00... More of this article »
Zenas BioPharma (NASDAQ:ZBIO) Price Target Raised to $21.00 at Morgan Stanley
Zenas BioPharma (NASDAQ:ZBIO – Free Report) had its price target upped by Morgan Stanley from $19.00 to $21.00 in a report issued on Tuesday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. A... More of this article »
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $136.00 at Morgan Stanley
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price objective reduced by Morgan Stanley from $150.00 to $136.00 in a report published on Tuesday morning,Benzinga reports. They currently have an overweight rating... More of this article »
Navan (NASDAQ:NAVN) Now Covered by Analysts at BMO Capital Markets
BMO Capital Markets began coverage on shares of Navan (NASDAQ:NAVN – Free Report) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $13.00 target price... More of this article »
Kaltura (NASDAQ:KLTR) Given “Buy” Rating at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Kaltura (NASDAQ:KLTR – Free Report) in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a $3.00 price objective on... More of this article »
Adecoagro (NYSE:AGRO) Upgraded to Equal Weight at Morgan Stanley
Morgan Stanley upgraded shares of Adecoagro (NYSE:AGRO – Free Report) from an underweight rating to an equal weight rating in a report issued on Tuesday, MarketBeat Ratings reports. They currently have $13.00 price objective... More of this article »
QuinStreet (NASDAQ:QNST) Now Covered by Northland Securities
Northland Securities assumed coverage on shares of QuinStreet (NASDAQ:QNST – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $17.00 price target... More of this article »
Edgewise Therapeutics’ (EWTX) Outperform Rating Reaffirmed at Wedbush
Wedbush reaffirmed their outperform rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They currently have a $32.00 price target on the stock. Several... More of this article »
Stoke Therapeutics (NASDAQ:STOK) Given New $40.00 Price Target at Needham & Company LLC
Stoke Therapeutics (NASDAQ:STOK – Free Report) had its price objective raised by Needham & Company LLC from $35.00 to $40.00 in a research note released on Tuesday,Benzinga reports. They currently have a buy rating on the... More of this article »
PLAYSTUDIOS’s (MYPS) Hold Rating Reaffirmed at Benchmark
Benchmark reiterated their hold rating on shares of PLAYSTUDIOS (NASDAQ:MYPS – Free Report) in a research note released on Tuesday, MarketBeat reports. Several other research firms also recently issued reports on MYPS. Weiss... More of this article »
Lifecore Biomedical (NASDAQ:LFCR) Upgraded to Outperform at Barrington Research
Barrington Research upgraded shares of Lifecore Biomedical (NASDAQ:LFCR – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Tuesday morning, Marketbeat.com reports. The... More of this article »
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to “Overweight” at Piper Sandler
Piper Sandler upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a neutral rating to an overweight rating in a research note issued to investors on Tuesday, MarketBeat reports. Piper Sandler currently has... More of this article »
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $139.00 by Analysts at Bank of America
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Bank of America from $145.00 to $139.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $130.00 Price Target at Needham & Company LLC
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price objective trimmed by Needham & Company LLC from $139.00 to $130.00 in a research note released on Tuesday,Benzinga reports. The firm currently has a buy rating... More of this article »
Zenas BioPharma (NASDAQ:ZBIO) Given Buy Rating at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Zenas BioPharma (NASDAQ:ZBIO – Free Report) in a report released on Tuesday morning,Benzinga reports. They currently have a $44.00 price objective on the stock. Several... More of this article »
Ichor (NASDAQ:ICHR) Upgraded by Stifel Nicolaus to “Buy” Rating
Stifel Nicolaus upgraded shares of Ichor (NASDAQ:ICHR – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday morning, Marketbeat reports. The firm currently has $55.00 target price... More of this article »
Target Hospitality (NASDAQ:TH) Rating Increased to Outperform at Oppenheimer
Oppenheimer upgraded shares of Target Hospitality (NASDAQ:TH – Free Report) from a market perform rating to an outperform rating in a research note issued to investors on Tuesday morning, MarketBeat reports. They currently have... More of this article »
Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at TD Cowen
TD Cowen initiated coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The firm issued a buy rating on the biopharmaceutical company’s... More of this article »
Li Auto (NASDAQ:LI) Downgraded by The Goldman Sachs Group to “Neutral”
The Goldman Sachs Group lowered shares of Li Auto (NASDAQ:LI – Free Report) from a buy rating to a neutral rating in a report released on Tuesday, Marketbeat Ratings reports. The Goldman Sachs Group currently has $19.00 price... More of this article »
Mosaic (NYSE:MOS) Price Target Raised to $32.00 at Canadian Imperial Bank of Commerce
Mosaic (NYSE:MOS – Free Report) had its price objective boosted by Canadian Imperial Bank of Commerce from $29.00 to $32.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Canadian Imperial Bank of... More of this article »
CVR Energy (NYSE:CVI) Given New $32.00 Price Target at Mizuho
CVR Energy (NYSE:CVI – Free Report) had its price target increased by Mizuho from $28.00 to $32.00 in a research report released on Tuesday,Benzinga reports. They currently have an underperform rating on the oil and gas company’s... More of this article »
Delek US (NYSE:DK) Price Target Raised to $54.00 at Mizuho
Delek US (NYSE:DK – Free Report) had its target price hoisted by Mizuho from $51.00 to $54.00 in a research note published on Tuesday morning,Benzinga reports. They currently have an outperform rating on the oil and gas company’s... More of this article »
Highwoods Properties (NYSE:HIW) Given New $23.00 Price Target at Truist Financial
Highwoods Properties (NYSE:HIW – Free Report) had its target price lowered by Truist Financial from $29.00 to $23.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a hold rating on the real... More of this article »
CONMED (NYSE:CNMD) Downgraded by Piper Sandler to Neutral
Piper Sandler downgraded shares of CONMED (NYSE:CNMD – Free Report) from an overweight rating to a neutral rating in a research note published on Tuesday morning, MarketBeat Ratings reports. The firm currently has $39.00 price... More of this article »
BETA Technologies (NYSE:BETA) Price Target Lowered to $38.00 at The Goldman Sachs Group
BETA Technologies (NYSE:BETA – Free Report) had its price target decreased by The Goldman Sachs Group from $43.00 to $38.00 in a research note published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy... More of this article »
EQT (NYSE:EQT) Given New $72.00 Price Target at JPMorgan Chase & Co.
EQT (NYSE:EQT – Free Report) had its price objective upped by JPMorgan Chase & Co. from $68.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have an overweight rating on the oil and gas producer’s... More of this article »
Kinder Morgan (NYSE:KMI) Given New $31.00 Price Target at Scotiabank
Kinder Morgan (NYSE:KMI – Free Report) had its target price upped by Scotiabank from $30.00 to $31.00 in a research report sent to investors on Tuesday,Benzinga reports. They currently have a sector perform rating on the pipeline... More of this article »
Howmet Aerospace’s (HWM) “Buy” Rating Reaffirmed at BTIG Research
BTIG Research reiterated their buy rating on shares of Howmet Aerospace (NYSE:HWM – Free Report) in a research report released on Tuesday,Benzinga reports. BTIG Research currently has a $275.00 price objective on the stock. Several... More of this article »